197 related articles for article (PubMed ID: 21469215)
1. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
Terevnikov V; Stenberg JH; Tiihonen J; Joffe M; Burkin M; Tchoukhine E; Joffe G
Hum Psychopharmacol; 2011 Apr; 26(3):188-93. PubMed ID: 21469215
[TBL] [Abstract][Full Text] [Related]
2. Adjunct mirtazapine for negative symptoms of schizophrenia.
Phan SV; Kreys TJ
Pharmacotherapy; 2011 Oct; 31(10):1017-30. PubMed ID: 21950644
[TBL] [Abstract][Full Text] [Related]
3. More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia.
Stenberg JH; Terevnikov V; Joffe M; Tiihonen J; Tchoukhine E; Burkin M; Joffe G
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1080-6. PubMed ID: 21402120
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
6. More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial.
Terevnikov V; Stenberg JH; Joffe M; Tiihonen J; Burkin M; Tchoukhine E; Joffe G
Hum Psychopharmacol; 2010 Aug; 25(6):431-8. PubMed ID: 20737516
[TBL] [Abstract][Full Text] [Related]
7. Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial.
Joffe G; Terevnikov V; Joffe M; Stenberg JH; Burkin M; Tiihonen J
Schizophr Res; 2009 Mar; 108(1-3):245-51. PubMed ID: 19144501
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Berk M; Ichim C; Brook S
Int Clin Psychopharmacol; 2001 Mar; 16(2):87-92. PubMed ID: 11236073
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
Caforio G; Di Giorgio A; Rampino A; Rizzo M; Romano R; Taurisano P; Fazio L; De Simeis G; Ursini G; Blasi G; Nardini M; Mancini M; Bertolino A
J Clin Psychopharmacol; 2013 Dec; 33(6):810-2. PubMed ID: 24113675
[No Abstract] [Full Text] [Related]
10. Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study.
Stenberg JH; Terevnikov V; Joffe M; Tiihonen J; Tchoukhine E; Burkin M; Joffe G
Int J Neuropsychopharmacol; 2010 May; 13(4):433-41. PubMed ID: 19941694
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
12. Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.
Cho SJ; Yook K; Kim B; Choi TK; Lee KS; Kim YW; Lee JE; Suh S; Yook KH; Lee SH
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):208-11. PubMed ID: 21095214
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
[TBL] [Abstract][Full Text] [Related]
15. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
16. The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.
Abbasi SH; Behpournia H; Ghoreshi A; Salehi B; Raznahan M; Rezazadeh SA; Rezaei F; Akhondzadeh S
Schizophr Res; 2010 Feb; 116(2-3):101-6. PubMed ID: 19959338
[TBL] [Abstract][Full Text] [Related]
17. Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-generation antipsychotics combination trial.
Terevnikov V; Stenberg JH; Tiihonen J; Chukhin E; Joffe M; Burkin M; Joffe G
Int J Neuropsychopharmacol; 2013 Aug; 16(7):1661-6. PubMed ID: 23217660
[TBL] [Abstract][Full Text] [Related]
18. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
20. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
Delle Chiaie R; Salviati M; Fiorentini S; Biondi M
Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
